Peter Crisp

1. Snapshot and testable edge thesis

The thesis predicts that unseen Crisp-sponsored files will contain his pre-outcome referral/sponsorship, explicit people/integrity and market-size tests, relevant specialist assignment, staged follow-ons, and specific board interventions. It predicts matched Crisp-sponsored results superior to same-vintage/stage/sector opportunities after controlling for Rockefeller access, vehicle, partner, and syndicate. It predicts partnership terms and reserves that actually changed company-duration decisions. Profile thesis

It is falsified or materially weakened if other partners own the famous decisions; the screen appears only in retrospective winners; ex-Apple cash flows are weak; board minutes show ceremonial or delayed intervention; vehicle terms were ordinary; or failures produced no stop rules or learning. The public record cannot presently decide between the favorable thesis and advantaged-platform stewardship. Researcher inference · strong. Retrieval ledger

2. Core philosophy

Crisp's cleanest quotable late statement is that people come first, alongside the requirement for a large market. Investor-stated · strong for the preference; insufficient public record for predictive efficacy. CHM oral history, printed p. 16

His broader 2008 account—paraphrased because NVCA restricts publication quotation—repeatedly returns to management integrity/persistence, patient capital, partner expertise, boards, and service. Those late themes form a stable retrospective philosophy, not proof of stable contemporaneous execution. Researcher inference · moderate. NVCA note · TALKS evolution

The bounded synthesis is: obtain relationship-based access; test people and market separately; put the appropriate specialist on the case; finance with capital whose duration fits the company; define board work as mechanisms rather than status; and keep losses and conflicting records visible. The first five are plausible Crisp models; the last is an analyst control required by the record.

3. Sourcing

How opportunities arrived

• Rockefeller brand and pre-existing funnel. The platform preceded Crisp and supplied staff, reputation, family capital, and portfolio relationships. Contemporaneous record · strong. TIME, 1959
• Direct initiative. Crisp's unsolicited 1959 approach turned a public article into institutional access. Retrospective witness · moderate; the original letter remains unavailable. CHM, pp. 7–9
• Trusted referrals and syndication. Markkula reached Venrock through younger Hank Smith; Arthur Rock organized Intel; Bob Waterman/Jimmy Walker appear around New England Nuclear; Shaw credits Crisp with IDEXX access. Retrospective witness · moderate except Apple's filed transaction. Markkula, pp. 25–27 · Shaw memorial

The repeatable part is tracing and cultivating trusted technical, financial, and founder relationships. The non-repeatable part is Rockefeller's name, balance sheet, historical position, and access. A modern analyst should record introducer, information advantage, conflicts, and whether the case would survive without the relationship. Researcher inference · strong.

4. Picking

Investor-stated · moderate: Crisp's late screen combines people—integrity, capability, persistence—with a large market and relevant technical judgment. CHM, pp. 12–17

What the public record does not establish is equally important: founder-reference procedure, market-sizing method, red flags, pricing thresholds, comparison set, pass reasons, kill criteria, IC quorum/vote, or calibration across ordinary cases. Apple is a documented investment but its original rationale is absent; Europe and Advent show that the screen did not eliminate integrity and insolvency risk. Researcher inference · strong. Apple lab · Europe lab

A disciplined reconstruction therefore asks two independent questions: “Do we have job-relevant evidence that this team can learn and act with integrity?” and “Is there a large, reachable customer problem under dated market conditions?” Passing one does not compensate automatically for failing the other.

5. Deal and portfolio mechanics

The only well-bounded entry is Apple: two 1978 purchases totaling $499,998 and 7.6% pre-IPO. Staging is behavior; no inspected source connects the second purchase to a named milestone or Crisp rule. Documented behavior · strong for transaction facts; insufficient public record for rationale. Apple prospectus, pp. 21–28

Price discipline, security preference, target ownership, reserves, follow-on formula, concentration, distribution, and exit rules remain unavailable. The visible eighteen-label universe, five named passes, plus five unresolved European slots is not a portfolio denominator; Apple is only a provisional economic leader and no Crisp/fund MOIC, IRR, or PME is published here. Pareto analysis

The supportable operating rule is narrower: stage capital only against explicit evidence, but do not attribute that rule historically to Crisp until original follow-on records are found. Researcher inference · strong as modern process; insufficient public record as Crisp doctrine.

6. Vehicle and incentive fit

Researcher inference · moderate: capital duration can be an investment capability only if legal duration, reserves, stakeholder patience, and opportunity cost actually support the next decision. “Patient” cannot mean funding without milestones. Vehicle analysis

Compared with a modern fixed-life fund, the supported difference is lower visible fundraising/liquidity pressure; fees, carry, term, recycling, reserve ratio, and performance remain unavailable. Current vehicles are not valid proxies for the 1969 partnership.

Geographic authority, partnership regulatory status, succession allocation, and key-person clauses are insufficient public record; the European experiment establishes activity, not formal territorial authority. Public-board duties are visible, while the 1958 SBIC regime remains context rather than a Venrock classification. Detailed vehicle audit

7. Team attribution and work with founders

Crisp's record is institutionally collective. Laurance Rockefeller and family interests supplied the platform/capital; senior staff screened and governed; later partners specialized; founders operated; syndicate investors financed; and board representatives changed. Researcher inference · strong. People/capital map

Apple illustrates the rule: Markkula introduced the opportunity to younger Hank Smith, Venrock owned the position, partnership participants decided, Smith initially served on the board, and Crisp succeeded him in 1980. Intel illustrates the negative boundary: Arthur Rock and Charles B. Smith are supported actors; Crisp is not the source or director. Apple attribution grid · Intel statement

Founder work should be described mechanistically—access, recruiting, financing, audit, succession, strategy, or monitoring—and sourced to a decision. Shaw's IDEXX testimony supports access/mentorship but not the check, vote, board work, or economics. IDEXX route

8. Views on the craft

• Access versus selection: the record proves advantaged access more readily than incremental selection skill. Researcher inference · strong.
• Power law / concentration: Apple may dominate visible economics, but the missing cash-flow denominator prevents a literal power-law or 80/20 claim. Pareto
• Governance: long board service creates opportunities to help and to fail; title and tenure are not mechanisms. Apple adverse record
• Fund size and patience: durable capital can support longer horizons, but only with legal/economic terms and milestones. Investor-stated · moderate; researcher inference · provisional for performance.
• Exits: no general Crisp exit doctrine is established; a company acquisition or IPO does not reveal investor return.
• Greatness: the public record supports institution building and stewardship more strongly than personal alpha. Researcher inference · strong.

9. Signature bets and decision process

Use the no-hindsight labs rather than outcome summaries:

1. Apple: shared referral, staged 1978 financing, Smith-to-Crisp board succession, and unresolved economics.
2. New England Nuclear: first reported sponsorship under predecessor capital and a later memory correction.
3. Advent: a mandatory failure lab where the present invest/pass answer is “insufficient evidence.”
4. European experiment: cohort failure, cross-border controls, and allegation boundaries.

Each ends with invest/pass, kill criteria, ownership/terms, next-check milestones, and the sourced actual outcome. None supplies an omniscient historical rationale.

10. Mental models and maxims

The reconciled inventory contains five supportable models; slogans, outcomes, and analyst controls are excluded rather than inflated.

1. Trace the introducer; separate access from selection — origin: Rockefeller approach and repeated referral chains.
2. Require both people evidence and a reachable large market — origin: Crisp's 2018 direct statement, bounded by failures.
3. Match capital duration to company duration — origin: Venrock formation and late capital-duration account.
4. Match specialist expertise to the case — origin: staffed Rockefeller apprenticeship and later partner specialization.
5. Specify the governance mechanism; never count the board title — origin: repeated long-board practice plus Apple/AMSC counterevidence.

Excluded candidates include “gut feeling,” generic stage financing, “learn, earn, return,” geography, price discipline, ownership targets, reserve formulas, exit doctrine, and power-law construction. Model gaps

11. Evolution and contradictions

The philosophy appears rhetorically stable, but no public record shows a dated rule change after Advent, Europe, E&S, or Apple criticism. Stability of recollection is not stability of application. Researcher inference · strong. TALKS evolution

12. Failures and limits

• Advent: documented Chapter 11; thesis, capital response, recovery, and Crisp role absent. postmortem
• Europe: four of five reported losses and two bookkeeping allegations; names/legal records absent. Europe lab
• Evans & Sutherland: reported disappointment with incomplete funding/economic reconstruction.
• Apple governance: late disclosure, reported deference, allegations, and departure challenge a uniformly successful board story; no adjudicated personal wrongdoing.
• AMSC governance: litigation/settlement is adverse board evidence, not proof of a Venrock investment or personal misconduct.
• Selection bias: the denominator lacks ordinary companies, passes, follow-ons, write-offs, and cash flows.
• Era dependence: scarce capital, relationship syndication, and Rockefeller access are not modern base rates.

No documented post-failure process change surfaced. That absence is not proof none occurred; the HBS archive is the decisive route.

13. Historical operating environment

The 1958 SBIC statute expanded organized risk-capital policy, while Rockefeller's family program used its own capital and should not be labeled an SBIC. The 1959 TIME profile documents a scarce, relationship-driven field and an established Rockefeller platform. Intel's 1968 convertible financing shows syndication before Venrock; the 1969 partnership institutionalized a longer-duration pool. SBIC statute · TIME, 1959 · Intel memorandum

The 1979 prudent-man change belongs to the later institutional-capital expansion and cannot explain the 1969 formation. By the 1980s–1990s, specialist teams, larger capital supply, public-market liquidity, and public-board duties changed the environment. No inspected dimension-matched vintage/sector/stage base-rate series supports a numerical alpha claim. Researcher inference · moderate. Federal Register, 1979

14. Modern VC translation (as of 2026-08-20)

These are researcher inference · moderate, not claims that Crisp used current tools. The public sources establish current factual premises only weakly; applications are labeled hypotheticals and should be adapted to the analyst's actual vehicle, regulation, stage, and market.

15. Comparison with completed peers

The Laurance comparison is grounded in the 1959 TIME platform profile; Arthur Rock in the Intel financing record and Markkula Apple testimony; and Reid Dennis in his Berkeley oral history, printed pp. 22–40 and 49–68. Researcher inference · moderate.

Crisp appears more an institutional integrator than Rock’s person-centered financier or Dennis’s technical-financial selector. Laurance is the essential sponsor comparator, not a rival. The comparison is dimensional, not a greatness ranking. Researcher inference · moderate.

16. The strongest case against greatness

The skeptical thesis is that Crisp was an able steward and narrator inside an extraordinarily advantaged Rockefeller platform, not a demonstrably superior personal investor. Rockefeller supplied brand, patient capital, staff, and access; senior colleagues and later partners supplied judgment; founders and co-investors built companies. Apple came through Markkula and Hank Smith, with Crisp joining the board later. Intel predates Venrock and has no documented Crisp lead or board role. Board biographies are easily mistaken for funded deals, and the public denominator/cash flows are missing. Late recollections contain material date, amount, and bankruptcy errors. Europe, Advent, E&S, Apple criticism, and AMSC adversity weaken a seamless-excellence story. Researcher inference · strong. Profile audit

The favorable thesis wins only if original memos/votes show repeatable Crisp sponsorship and criteria, matched outcomes show incremental results, vehicle terms changed decisions, and board minutes show useful interventions. The skeptical thesis wins if Apple dominates, other partners own the work, ex-Apple performance is weak, board work is ceremonial/delayed, or failures produced no learning. Today both remain live; the public record favors institution-building evidence over personal-alpha evidence.

17. Analyst study guide, glossary, and go deeper

Recommended path

1. Profile for chronology and the testable thesis.
2. Source map, writings, and talks for access, rights, and memory boundaries.
3. Investments for the denominator, vehicle map, and four decision labs—Apple first, Advent as the failure lab.
4. Mental models for five evidence-bounded checklists.
5. Read the adversarial acceptance record.

Glossary

Reusable checklists

• Sourcing: who introduced it; why they had access; conflicts; independent channel; would the case survive without prestige?
• Diligence: job-relevant people evidence; integrity/reference disconfirmation; reachable market; technical/regulatory expert; dated risks; alternatives.
• IC: invest/pass; kill criteria; security/ownership; reserves; decision owner/dissent; next-check milestones; vehicle duration and LP constraints.
• Governance: explicit intervention hypothesis; information rights; recruiting/audit/capital/succession tasks; cadence; escalation/stop rule; measured result.
• Attribution/economics: source, sponsor, diligence, approval, negotiation, board, follow-on, exit; vehicle; ownership/dilution; dated cash flows; fees/carry; benchmark.

Best sources and retrieval priorities

The 2008 NVCA oral history is broadest but paraphrase-only; the 2018 CHM history is the clearest concise statement; the Apple prospectus is the best contemporaneous transaction control; and the HBS Peter O. Crisp papers, call Mss:784 1946-2008 C932, are the decisive unresolved route. Retrieve partnership/cash-flow records, original memos/votes, board minutes, and failure files before upgrading the thesis.

Pareto 80/20 — what drove the record

The public record does not support a literal 80/20 calculation, a complete Venrock portfolio ranking, or a Peter Crisp personal return. It exposes eighteen named company/relationship labels, five named passes, plus five unnamed European venture slots, with unresolved overlap, and mixes financed companies, predecessor capital, board-only relationships, and favorable retrospectives. Apple is the only defensible provisional economic leader because its entry basis and ownership are in a primary filing; even there, realized cash flows, disposition dates, fees, carry, and Crisp's personal economics are absent. Researcher inference · strong. Apple prospectus, printed pp. 21–28 · Venrock portfolio disclaimer

Ex-Apple stress test: no inspected cash-flow schedule allows a return measure for the record with or without Apple. Removing Apple leaves one reported company exit value and selected success/failure narratives, not a rankable fund. Nicholas's reported Apple-exclusion analysis remains unusable until its table, notes, cash-flow dates, benchmark, and gross/net method are inspected lawfully. Researcher inference · strong. VC: An American History access note

Evidence boundary and searched denominator

Scope and inclusion rules

The searched universe covers Crisp's 1960–1997 Rockefeller/Venrock investing career and named late board relationships. Searches and source inspection included both Crisp oral histories, HBS/Rockefeller archive catalogs, Apple/Intel/AMSC filings, court records, partner/founder oral histories, contemporaneous press, selected firm history, and the current Venrock disclaimer. An issuer enters the candidate ledger if a reviewed source reports financing, a portfolio relationship, or a potentially relevant board relationship; each row is then classified rather than presumed funded. Researcher inference · strong. Source-map coverage

Coverage fraction: not computable. The denominator of funded Crisp-linked companies is unknown; five European slots may duplicate named issuers; the current firm site disclaims completeness and positive-performance selection; follow-ons and spinouts are not deduplicated; five named passes are known but the complete opportunity and ordinary-outcome set is missing. Researcher inference · strong. Venrock disclosure · HBS archive route

What the denominator is not

• The reported “43 public/private boards” is a company-biography claim, not forty-three investments. AMSC 2011 10-K, director biography
• Current Venrock-selected companies are not a historical portfolio ledger. Venrock disclaimer
• Intel's aggregate $2.5m debentures are not a Rockefeller allocation or Crisp check. Intel 1968 financial statement, pp. 2–3 and 6
• Apple vehicle holdings are not Crisp personal holdings or realized proceeds. Apple prospectus, pp. 21–28
• Board service, philanthropy, and later family-trust work do not enter the funded denominator without a transaction record.

Historical market, regulatory, and base-rate context

1959–1968: scarce organized venture supply and relationship syndication

The 1959 TIME profile shows that Rockefeller already employed a staffed, high-risk investment program before Crisp arrived. The 1958 Small Business Investment Act expanded an adjacent policy channel, but no evidence makes the Rockefeller program an SBIC. Semiconductor formation relied on small professional networks, corporate spinouts, convertibles, and syndication; Intel's 1968 note financing predates Venrock. Contemporaneous record · strong for the institutional setting; researcher inference · moderate for how it shaped Crisp's opportunity set. TIME, 1959 profile · Small Business Investment Act · Intel financing memorandum

1969–1981: durable family capital meets expanding technology markets

Venrock's formation pooled holdings and committed capital into a partnership that Crisp describes as patient. That could reduce fundraising and forced-liquidity pressure relative to a fixed-life LP fund, while concentrating family governance and making public performance comparison difficult. The 1979 prudent-man rule change sits inside the later institutional-capital expansion, but it did not cause the 1969 formation. Investor-stated · moderate for capital duration; researcher inference · moderate for incentive effects. CHM interview, printed pp. 12–16 · 1979 Federal Register

Apple in 1978 was a private personal-computer company with material product and distribution uncertainty; the prospectus later documents staged Venrock purchases, not a single hindsight-free certainty. Advent's 1981 bankruptcy and contemporary venture boom reporting warn against inferring a universally favorable base rate from famous survivors. Apple prospectus, pp. 21–28 · TIME, 1981

1980s–1990s: specialization, public markets, and governance exposure

Venture capital supply, technology sectors, and institutional LP participation expanded. Venrock added specialist partners, while Crisp accumulated long public/private board tenures. Public-company directorship created audit, disclosure, compensation, succession, and litigation exposure absent from an entry-only narrative. Apple's 1994 late report and 1996 board criticism are therefore part of the historical governance record, not side notes. Researcher inference · moderate. Apple 1994 proxy, Section 16 disclosure · Los Angeles Times, 1996

No public contemporary dataset in the inspected corpus supplies a dimension-matched vintage/sector/stage base rate. Qualitative context is used rather than manufacturing one.

Vehicle economics and incentives

Geographic authority: the reported European experiment proves cross-border activity, but no inspected agreement allocates geographic authority among Crisp, partners, family subscribers, or vehicles; insufficient public record. Regulation: the 1958 SBIC regime is context, not proof Venrock was an SBIC; public-board securities and disclosure duties are visible in Apple/AMSC filings, while partnership regulatory status is insufficient public record. Succession and key-person continuity: HBS documents senior predecessors, later specialist partners, and Crisp's 1980–1997 leadership, but no key-person clause, removal right, ownership transition, or succession allocation was inspected. Researcher inference · moderate for chronology linkage and insufficient public record for contractual effects. HBS collection · Apple 1994 proxy, Section 16 disclosure

Researcher inference · moderate: durable capital plausibly enabled patience, but “patient” is not economically meaningful without duration, reserve, liquidity, and opportunity-cost records. A modern fixed-life LP fund is comparable only on those dimensions; current management entities must not be projected backward. HBS biography/collection · CHM interview, pp. 21–23

People, capital, and influence map

Eight-role attribution grid for material cases

Comprehensive deal ledger

Thermo companies remain separate issuer rows but one linked parent/spinout family until securities and capitalization records establish investments and deduplication. The five European slots remain a cohort, not five additive named companies.

Pass and miss ledger

These five names are an anti-portfolio sample, not a complete pass denominator. No missed-return figure is calculated. The record also reports a change from reluctance toward therapeutics to later specialist biotechnology investing, but it does not establish a dated Crisp-authored rule change. Researcher inference · moderate.

Ex-ante forensic case studies and decision labs

Case 1: Apple — referral, staged financing, and board succession

Information before the January 1978 purchase. Markkula had joined Jobs and Wozniak, developed the plan, and used the younger Hank Smith/Venrock connection. The public record does not expose Venrock's original memo, customer evidence, forecasts, valuation debate, attendee list, dissent, or vote. Retrospective witness · moderate for referral; insufficient public record for IC mechanics. Markkula oral history, printed pp. 25–27

Dated decisions. Venrock bought in January and September 1978; the two purchases totalled $499,998. The prospectus records 3,801,822 split-adjusted shares/7.6% before the IPO, Hank Smith's prior directorship, and Crisp's October 1980 appointment. Staging is documented; the milestones unlocking the second purchase are not. Documented behavior · strong. Apple prospectus, printed pp. 21–28

Risks and alternatives then. A no-hindsight IC would have tested product reliability, manufacturing, distribution, working capital, founder/management fit, market size, competition, security terms, reserves, and whether the partnership could support governance. The surviving evidence does not identify historical kill criteria. Researcher inference · strong as method, not historical fact.

Outcome and governance. Apple went public in 1980; Crisp served until June 1996. Later board criticism, a late Section 16 report, shareholder allegations, and settlement-related governance changes prevent treating tenure as uniformly effective. None is an adjudicated finding that Crisp committed fraud. Apple 1994 proxy, Section 16 disclosure · Los Angeles Times, “A Question of Leadership” · SFGate, opening departure paragraphs · Apple 1998 10-K405, litigation section

Decision exercise — before outcome:

• Invest/pass: decide on the January 1978 evidence only; state the missing fact that determines the vote.
• Kill criteria: product reliability, manufacturing, distribution, management conflict, or cash evidence below a stated threshold.
• Ownership/terms: choose security, target ownership, governance/information rights, reserve, and dilution tolerance appropriate to the risk.
• Next-check milestones: specify customer, product, team, manufacturing, and cash evidence required before the September check.

Actual decision/outcome: Venrock staged two 1978 purchases and held the disclosed pre-IPO stake; Crisp later succeeded Smith on the board. Realized partnership and personal economics remain unknown. Documented behavior · strong.

Case 2: New England Nuclear — first sponsorship under predecessor capital

Information and decision boundary. Crisp remembers this as his first recommendation and first board, within the Rockefeller program rather than Venrock. Bob Waterman, Jimmy Walker, senior staff, and family subscribers belong in the decision environment. The original proposal, science/regulatory diligence, security, allocation, board minutes, and decision are absent. Retrospective witness · moderate. NVCA note

Outcome after the frozen decision. Contemporary reporting places DuPont's acquisition in 1981 at roughly $430m in stock, correcting Crisp's later 1972/~$250m memory. The transaction value does not reveal predecessor ownership, dilution, distributions, or Crisp economics. Washington Post, 1981

Decision exercise — before outcome:

• Invest/pass: decide using only early-1960s scientific, regulatory, team, and customer evidence.
• Kill criteria: failed validation, unsafe or regulatorily blocked product, weak hospital demand, or financing need beyond vehicle capacity.
• Ownership/terms: specify security, downside protection, board/information rights, ownership, and reserve for technical risk.
• Next-check milestones: define validation, hospital adoption, regulatory, team, and cash thresholds for follow-ons.

Actual decision/outcome: Crisp reports sponsorship/board service; Rockefeller capital participated; DuPont later acquired the company. Exact return and causality remain unavailable.

Case 3: Advent — bankruptcy versus the no-bankruptcy memory

Information before financing. The present public record does not supply Advent's original thesis, sponsor, security, ownership, forecasts, cash plan, reserves, or board interventions. That absence prevents an omniscient failure narrative. Insufficient public record.

Outcome. Advent filed voluntary Chapter 11 on March 17, 1981. This defeats Crisp's later categorical memory that no Venrock company went bankrupt, while leaving check, write-off, recovery, and Crisp role unknown. Contemporaneous record · strong. In re Advent Corp., opening factual paragraph

Decision exercise — before outcome:

• Invest/pass: pass / insufficient evidence; state the minimum evidence needed to reconsider.
• Kill criteria: customer concentration, gross margin, burn, working capital, covenant, or refinancing metrics outside pre-agreed bounds.
• Ownership/terms: require a security, information/covenant package, board rights, ownership, and reserve sized to insolvency risk.
• Next-check milestones: demand validated orders, margin/cash conversion, runway, covenant compliance, and committed refinancing before rescue capital.

Actual decision/outcome: Venrock was associated with Advent and the company entered Chapter 11. No documented subsequent Crisp process change surfaced.

Case 4: The European experiment — cohort failure and integrity risk

Original thesis and portfolio choice. Crisp reports a deliberate five-company European experiment; the likely thesis was geographic diversification/access, but company names, local partners, checks, approval records, and dated theses are unavailable. Retrospective witness · provisional for the cohort; researcher inference · provisional for motive. NVCA note

Warnings, capital response, and outcome. He remembers four losses, suspected bookkeeping fraud in two Italian companies, and one Israeli medical-electronics winner. “Fraud” remains a participant allegation absent company and legal records. There is no public follow-on/stop ledger or documented later process change. Retrospective witness · provisional.

Decision exercise — before outcome:

• Invest/pass: pass unless local audit, governance, legal, currency, reporting, and partner capability meet named thresholds.
• Kill criteria: unexplained accounting differences, unverifiable customers/cash, related-party conflicts, or denied information rights.
• Ownership/terms: specify staged securities, audit/information/board rights, control protections, currency limits, ownership, and reserve.
• Next-check milestones: require clean audited reporting, customer verification, legal compliance, governance recruitment, and operating targets before follow-ons.

Actual decision/outcome: The reported cohort produced four losses and one winner; exact companies, overlap, capital, and recoveries remain unresolved.

Portfolio-level forensics

The observed denominator is the bounded candidate ledger above, not a fund. Selection and survivorship bias are severe. Public promotional claims—aggregate companies, revenue, market cap, or CAGR—lack person attribution, cash-flow timing, fee/carry basis, benchmark, and complete denominator and are not used. Researcher inference · strong.

Failure, miss, and anti-portfolio postmortems

Advent

• Original thesis/evidence: unavailable. Insufficient public record.
• Warnings and capital response: unavailable. Insufficient public record.
• Governance/stop: unavailable. Insufficient public record.
• Outcome: Chapter 11 in 1981. Contemporaneous record · strong. In re Advent, opening factual paragraph
• Claimed lesson/process change: none documented; later no-bankruptcy memory conflicts with the case.
• Counterfactual: without the original memo and recovery record, neither avoidability nor total loss is established.

European cohort

• Original thesis/evidence: geographic experiment reported; company-level theses absent. Retrospective witness · provisional. NVCA note
• Warnings: two Italian-company bookkeeping/integrity allegations; exact timing and verification absent. Retrospective witness · provisional. NVCA note
• Capital/governance/stop: unavailable. Insufficient public record.
• Outcome: four losses, one Israeli survivor, all participant-reported. Retrospective witness · provisional. NVCA note
• Claimed lesson: cross-border monitoring and accounting risk are implicit; no documented process change. Researcher inference · provisional. NVCA note
• Counterfactual: local partners, audit rights, staged capital, or different selection might have mattered, but the record cannot test them.

Evans & Sutherland

• Original thesis/evidence: technology relationship named; dated memo absent. Retrospective witness · provisional. NVCA note
• Warnings/capital/governance: unavailable. Insufficient public record.
• Outcome: Crisp later characterized the outcome as disappointing; return and even precise funded relationship remain unresolved. Retrospective witness · provisional. NVCA note
• Lesson/process change: no documented change. Insufficient public record.

Apple governance adverse record

• Investment outcome versus board quality: a famous company outcome does not settle whether the board governed well in 1994–1996. Researcher inference · strong. Apple prospectus, printed pp. 21–28 · Los Angeles Times, “A Question of Leadership”
• Warning evidence: late Section 16 report, contemporary criticism of deference, board turnover, and shareholder allegations. Contemporaneous record · strong for filing and tenure; contemporaneous record · moderate for deference. Apple 1994 proxy, Section 16 disclosure · Los Angeles Times, “A Question of Leadership”
• Disposition: Crisp left in June 1996; later settlement materials record governance actions, not adjudicated Crisp misconduct. Contemporaneous record · moderate. SFGate, opening departure paragraphs · Apple 1998 10-K405, litigation section
• Lesson: investment selection, long tenure, compliance, monitoring, succession, and board effectiveness require separate evaluation. Researcher inference · strong. Apple 1994 proxy, Section 16 disclosure · Apple 1998 10-K405, litigation section

American Superconductor governance adverse record

• Investment status: funding unverified; treat as board evidence. Documented behavior · strong for board service only. AMSC 2011 10-K
• Outcome: securities litigation named directors including Crisp and settled for $10m. Contemporaneous record · strong for case and settlement, not wrongdoing. Lenartz order · settlement notice
• Boundary: allegations/settlement are not findings of personal wrongdoing and do not establish Venrock loss or Crisp return. Researcher inference · strong. Lenartz order · settlement notice

Uncertainty and retrieval ledger

1. Complete denominator: obtain the HBS company list, rejected proposals, opening contributed-asset schedule, follow-on ledger, write-offs, exits, and later fund-by-fund allocations; deduplicate issuers, spinouts, and the Europe cohort.
2. Economics: retrieve dated calls/distributions, securities, ownership, dilution, fees, carry, residual values, benchmarks, and audit basis before computing company/fund/person MOIC, IRR, PME, or Pareto contribution.
3. Vehicle documents: partnership agreements and amendments for 1969 Venrock and later vehicles; family/nonprofit interests; governance, reserves, duration, liquidity, succession, and key-person provisions.
4. Decision rights: original memos, partner attendees/votes, dissent, negotiation, information rights, board minutes, follow-ons, recruiting, stop decisions, and exits for every material case.
5. Apple: purchaser schedules through disposition, Venrock IC files, both Smith identities, second-check milestone, board minutes, committee files, compensation, and settlement record.
6. New England Nuclear: subscription, capitalization, board, acquisition, and distribution records to reconcile the retrospective date/value error.
7. Intel: Rockefeller subscriber allocation and board records; no Crisp role should be inferred without them.
8. Failures: Advent proof of claim/recovery and board files; identities/legal records for all five Europe slots; Evans & Sutherland security and outcome records.
9. Thermo/IDEXX/AMSC and board-only candidates: prove or exclude transaction, vehicle, sponsor, ownership, follow-on, disposition, and personal interest; link parent/spinouts before counting.
10. Performance scholarship: lawfully inspect VC: An American History pp. 167–172, underlying HBS tables/notes, and any reported Apple-exclusion measure with complete methodology.

The most defensible assessment is narrower than the legend: Crisp helped institutionalize durable Rockefeller venture capital, participated in Apple's partnership decision and long governance, and operated inside a specialist team with privileged access. The public record does not establish a complete Crisp portfolio, person-level economics, a literal Pareto split, or causality between his board presence and company outcomes. Researcher inference · strong.

Coverage and evidence base

The priority WRITINGS inventory reconciles to five ★★★/★★ rows but three underlying source families: (1) the Done Deals Crisp/Venrock chapter and its retailer manifestation; (2) the HBS Peter O. Crisp papers and their Venrock child series; and (3) Tom Nicholas's secondary VC: An American History. Source-map writings section

Accessible attributable Crisp written-body denominator: 0. Deep-analysis numerator: 0. A percentage is not meaningful because the archive's 74 components are catalog units rather than a verified writings count. The public record searched in SCOUT did not establish a standalone Crisp book, essay archive, firm-post series, public LP/shareholder letters, or sole-authored published paper. HBS scope and content

The HBS 2024 award page/brochure, Jupiter donor profile, oral histories, podcasts, OneWire summary, CHM clips, filings, press, and memorials remain outside this denominator: they are editorial profiles, spoken evidence, institutional records, or secondary reporting rather than Crisp-authored writing. HBS award page · Jupiter profile

Source-by-source access and analytical record

Done Deals: Peter Crisp / Venrock Associates (2000)

The lawful catalog record supports only publication metadata: Udayan Gupta edited a collection of first-person venture accounts and assigned the Venrock chapter to Peter Crisp at printed pp. 107–112. BiggerBooks, summary and table of contents The inspected Google route states that no ebook is available and exposes no chapter body. Google Books record

• Argument and reasoning: insufficient public record; no lawful body was read.
• Evidence and examples: insufficient public record; no claim is imported from search snippets or unauthorized mirrors.
• Assumptions and decision rules: insufficient public record.
• Operational implications: only a retrieval rule is supportable—obtain the licensed six-page chapter before attributing doctrine.
• Biography/evolution: publication in 2000 places the edited recollection after Crisp's 1997 Venrock retirement, so it is retrospective by construction; that chronology does not reveal its actual content. HBS chronology
• Authorship: edited first-person participant account, not safely classifiable as sole-authored prose or a verbatim transcript.
• Evidence label: contemporaneous record · strong for metadata; researcher inference · insufficient public record for content.

Peter O. Crisp papers and Venrock series (1946–2008)

HBS describes the collection as 1.5 linear feet in three boxes/six folders with records concerning investments, performance and partner analyses, Crisp notes, speeches, and Rockefeller/Venrock history. HBS finding aid, “Scope and content” The Venrock series is a component view of that same archive. HBS Venrock series

• Argument and reasoning: not content-analyzable from container descriptions.
• Evidence and examples: the catalog proves categories of records exist, not what any document says.
• Assumptions and decision rules: cannot be inferred from file titles, custody, or later oral history.
• Operational implications: build an item ledger before reading; distinguish authored, received, collaborative, institutional, and administrative documents.
• Biography/evolution: the date span could support a contemporaneous intellectual chronology after retrieval, but chronological proximity alone is not causation or authorship.
• Access boundary: item bodies are largely reading-room, HarvardKey, or digitization dependent. No outreach, paid order, or archive visit was authorized. Finding-aid or body access would not itself confer copyright, quotation, or reproduction permission; rights require item-level review.
• Evidence label: contemporaneous record · strong for custody/metadata; insufficient public record for content.

VC: An American History (2019)

Tom Nicholas's study is secondary analysis that draws on the Crisp papers; it belongs in the control layer, not the Crisp-writing numerator. Google Books record, relevant pp. 167–172 Any portfolio or Apple-exclusion result must be reproduced from the full table, notes, cash flows, dates, benchmark, and gross/net definition before use.

• Argument/reasoning/evidence: partial-preview secondary material; not analyzed as a Crisp work.
• Operational implication: use it to locate primary boxes/tables and test interpretations, never to convert archive-based scholarship into Crisp's own words.
• Evidence label: researcher inference · moderate as historical control; not applicable as Crisp-authored evidence.

Cross-source synthesis: what the written record can and cannot establish

There is no accessible written corpus from which to infer Crisp's philosophy, intellectual evolution, or writing-specific contradictions. Repetition between late oral histories and secondary books would not cure that absence because those are different evidence types and often depend on the same archival or participant source. Evidence label: researcher inference · strong for the source-accounting conclusion, based on the reconciled catalog and access routes above.

Three defensible conclusions follow:

1. Crisp's public legacy is oral- and archive-heavy, not publication-heavy. This is a statement about the located record, not a claim that he did not write privately. HBS collection scope
2. Editorial voice must remain separate from authored prose. Done Deals is edited first-person; HBS award copy and donor profiles are institutional/editorial; neither can silently become a Crisp essay. BiggerBooks summary · HBS award page
3. The archive may test or resolve later recollection. Contemporaneous notes, partner analyses, and performance files could resolve chronology, attribution, and economics conflicts identified in SCOUT, but unseen records cannot be presumed to support either favorable or skeptical narratives. HBS finding aid

Intellectual chronology, evolution, and contradictions

A writing-derived intellectual chronology is not currently constructible. The archive spans 1946–2008, Done Deals appeared in 2000, and Nicholas published in 2019, but dates alone do not disclose Crisp's arguments or how they changed. HBS finding aid Later phases may compare lawfully retrieved prepared speeches/memos with dated oral histories and deal records; until then, any narrative of stable patient capital, people-first selection, or governance evolution would be imported from spoken/secondary evidence rather than WRITINGS.

The most important contradiction is methodological: the record is rich enough to tempt synthesis yet too inaccessible to support writing-specific doctrine. The correct result is an explicit gap, not a compressed proxy analysis.

Corpus-handling and research rules

Rule 1 — Freeze the corpus before interpreting it

• Research rule (analyst): count underlying works, not catalogs, mirrors, or child finding aids.
• Diagnostic questions: Is the body visible? Who authored it? Is the text edited, transcribed, signed, or merely housed in the person's papers? Can every claim receive a page/section locator?
• Kill criterion: if only metadata or snippets are accessible, stop content analysis.
• Evidence label: researcher inference · strong, derived from the reconciled access record.
• Modern VC translation (as of 2026-08-20): the rule transfers directly to internal memos, newsletters, and AI-indexed archives. Searchability is not body access, custody is not authorship, and a model-generated summary is not a source. A modern analyst should require the original memo plus version/author provenance before treating it as an investor rule.

Rule 2 — Keep oral, editorial, and written evidence separate

• Research rule (analyst): an edited first-person chapter, interview transcript, institutional profile, and authored memo answer different questions.
• Diagnostic questions: Who selected and rewrote the language? Was the participant reviewing a past outcome? Are quotation rights restricted? Is there contemporaneous corroboration?
• Failure mode: laundering an interviewer's framing or editor's prose into an investor maxim.
• Evidence label: researcher inference · strong from the documented source types. Done Deals catalog · NVCA oral-history rights page
• Modern VC translation (as of 2026-08-20): retain source-type fields in knowledge systems; quote only from permitted originals and label retrospective accounts at the point of use.

Rule 3 — Treat unavailable primary records as falsifiers, not decoration

• Research rule (analyst): name the exact boxes, folders, tables, and agreements that could change the thesis.
• Diagnostic questions: Would original cash flows alter the Apple-outlier conclusion? Would partner memos move sourcing credit from Crisp? Would a prepared speech show that a purported rule existed before the result?
• Evidence label: researcher inference · moderate because the archive categories are known but bodies are unseen. HBS scope and content
• Modern VC translation (as of 2026-08-20): an IC should separate “not found,” “not accessible,” and “does not exist.” The likely misuse is calling an evidence gap neutral when the missing memo or denominator could reverse the decision.

Best writings and unresolved record

Because no attributable Crisp body was accessible, this is a ranked retrieval list, not a fabricated “five best writings” ranking:

1. Peter Crisp/Venrock chapter in Done Deals, printed pp. 107–112 — only located long-form chapter attributed to Crisp; obtain a licensed copy. Catalog
2. Catalog-described notes and speeches in Mss:784 1946-2008 C932, potentially attributable to Crisp — highest potential for contemporaneous philosophy and evolution; item-level authorship/body access unresolved. HBS collection
3. Venrock partner analyses and investment-performance records — highest potential to compare rhetoric with decisions/economics; these may be institutional or collaborative rather than Crisp-authored. HBS Venrock series Unranked lead: Crisp's 1959 letter to Laurance Rockefeller remains unverified outside the ranked corpus until its existence and custody are established.

Unresolved work is precise: obtain a lawful Done Deals body; build an item-level HBS ledger with title/date/container/author/addressee/access; request only authorized digitization or conduct reading-room research; verify whether the 1959 letter survives; and identify prepared speech texts separately from event records. Until then, the WRITINGS phase supports source discipline and access boundaries—not a Crisp philosophy distilled from prose.

Literal corpus reconciliation

The ten direct-voice rows in the source map collapse to six route families and only two fully accessible, distinct long-form Crisp transcripts. This count separates works from mirrors, clips, editorial packaging, and uncaptured media. It is an inventory, not a completeness percentage. Researcher inference · strong. Annotated source map

The accessible spoken denominator is therefore 10 rows → 6 route families → 2 full independent long transcripts. A coverage fraction is not computable because the HBS program may contain multiple distinct works and no complete universe of private speeches, appearances, or recordings is public. Researcher inference · strong. HBS award-media boundary

Dated source-by-source guide

2008 — NVCA/Bancroft oral history

This is the richest public Crisp body: biography, Rockefeller apprenticeship, early investments, Venrock formation, Apple, the European experiment, boards, failures, and industry change. Its value is decision density; its limits are late memory, absent deal records, selection, and an explicit publication-rights restriction. No verbatim Crisp language from it appears in this package. Retrospective witness · moderate. Full note

Circa 2013 — OneWire/Open Door Apple route

Only a derivative summary survives in the inspected route. It presents a compressed Apple story centered on intuition and remembered stake/date shorthand. The primary prospectus—not the retelling—controls the 1978 purchases, $499,998 aggregate basis, pre-IPO position, Hank Smith's earlier board representation, and Crisp's October 1980 succession. Retrospective witness · provisional for the derivative account; documented behavior · strong for the filing. Route note · Apple 1980 prospectus, printed pp. 21–28

2018 — CHM oral history

The shorter later interview makes Crisp's people-first and large-market screens explicit, revisits stable capital and specialization, and clarifies that Charles B. Smith—not Crisp—was the supported Rockefeller-side Intel board actor. It also contains a likely 1968/1960 chronology error and uncertain monetary memories. Investor-stated · strong for stated preferences; Retrospective witness · moderate for historical execution; Retrospective witness · provisional for uncorroborated figures. Full note

2018 — Jupiter donor profile

The profile explains Crisp's “learn, earn, return” frame and later health-care service. It is useful for how he wanted service and philanthropy understood, but its institutional donor setting and editing limit its use as investment evidence. Investor-stated · moderate. Full note

2024 — HBS award-media family

HBS packages a late-life award profile, brochure, a 2:51 recipient-video route, and podcast links around achievement, company building, mentorship, and service. Award metadata is strong; editorial praise and aggregate career claims are not independent performance evidence. The two linked story bodies returned HTTP 403, so uninspected segments are excluded from content synthesis rather than represented by titles. Page access does not establish transcript or reproduction rights for linked media, and the separate NVCA restriction does not automatically govern this HBS family. Contemporaneous record · strong for the award; Insufficient public record for the media bodies. Family note

Current exhibit / 2026 memorial routes

CHM's The Next New Thing is a museum-context route and possible excerpt manifestation, not another Crisp interview: the inspected page exposed no distinct parent-asset or caption fingerprint. David Shaw's memorial is a favorable founder witness, not Crisp speech; the exact route recheck was rejected by the browser safety layer, and bounded exact-domain search exposed no separate film or transcript. These routes improve context and retrieval, not the independent direct-voice denominator. Researcher inference · strong. CHM note · IDEXX route note

Recurring frameworks and their strongest limits

People first, but not people alone

Crisp explicitly places people first and market size alongside them. Across the two long interviews, the reported screen includes management quality, integrity, persistence, a large market, technical competence, and capacity for a board relationship. Investor-stated · strong for the stated rule; researcher inference · insufficient public record for its calibration, rejection rate, or incremental predictive value. CHM transcript, printed pp. 12–17 · 2008 note

The strongest limit is selection bias: the public stories disproportionately feature New England Nuclear, Apple, Intel, Thermo Electron, and later favorable outcomes. Advent, Evans & Sutherland, Europe, and ordinary portfolio companies show that the screen did not eliminate product, timing, governance, or integrity failure. TIME, “Boom Time in Venture Capital” · 2008 note, failures

Patient capital as an institutional capability

Crisp repeatedly contrasts Rockefeller/Venrock capital with short fundraising and liquidity clocks. That design plausibly supported long board service and follow-on patience. It was an institutional resource supplied by family and nonprofit-linked capital, not a personal trait or proof of high return. Exact term, reserve, distribution, compensation, and decision-right provisions remain in uninspected partnership/archive records. Investor-stated · moderate for the preference; researcher inference · provisional for causality. CHM transcript, printed pp. 12–16 and 21–23 · HBS Crisp papers

Boards as the operating interface

Crisp's stories emphasize governance more than operating control: early support roles, New England Nuclear, sixteen years at Apple, Thermo companies, health institutions, and American Superconductor. The mechanism could include management assessment, recruiting, financing, and institutional continuity, but a board title does not identify a specific intervention or cause an outcome. Apple's 1996 criticism and later shareholder allegations are material counterevidence to a uniformly effective governance narrative. Researcher inference · moderate. Apple 1995 proxy · Los Angeles Times, “A Question of Leadership”

Specialist teams beat a lone generalist

Both long interviews name senior Rockefeller colleagues and later Venrock partners. The described transition from a generalist family office to partner specialization supports a team-based account of technology and health-care investing. Retrospective witness · moderate. It does not allocate sourcing, diligence, approval, board work, follow-ons, exits, or carry deal by deal. CHM transcript, printed pp. 20–21 · Anthony Evnin oral history, printed pp. 19–21 and 61–63

Intuition is a compressed label, not a process record

The derivative Apple route frames the decision as “gut feeling,” while the fuller corpus points to Markkula's referral, Hank Smith's access, partnership discussion, technical/product evaluation, and staged purchases. Researcher inference · strong: later intuition language cannot replace a dated memorandum, dissent record, terms, milestones, or partner vote. OneWire route note · Mike Markkula oral history, printed pp. 25–27

Intellectual evolution and stable tensions

The defensible conclusion is rhetorical stability—not proven execution stability. People, large markets, patient capital, boards, teams, and service recur across late accounts. Missing contemporaneous memos and the same narrator's repeated stories prevent using repetition as independent confirmation or efficacy evidence. Researcher inference · strong.

Recollection versus contemporaneous control

Biography, deal, and attribution leads

Reconstructed spoken-record playbook

This is an analyst reconstruction, not a Crisp-authored checklist. Every step is researcher inference · moderate and should be tested against dated deal records.

1. Name the capital and decision body. Separate Rockefeller staff, family subscribers, Venrock partnership assets, later funds, trusts, and Crisp personally.
2. Trace the referral. Identify the introducer, relationship advantage, sponsor, and evidence available before the result.
3. Test people and market independently. Record management references, integrity evidence, customer need, market size, competition, and disconfirming facts.
4. Match expertise to the case. Assign a partner or adviser with the relevant technical/health-care competence; do not infer expertise from a title.
5. Stage capital against milestones. Recover the security, ownership, reserves, follow-ons, dilution, and next-check evidence rather than treating patience as unlimited funding.
6. Specify the board mechanism. State whether governance meant recruiting, financing, audit, succession, strategy, or monitoring; board membership alone is not contribution.
7. Keep an exception ledger. Record Advent, Europe, Evans & Sutherland, challenged Apple governance, ordinary outcomes, and passes alongside famous winners.
8. Separate company outcome from vehicle return. Require cash flows, ownership, timing, fees, carry, and distributions before stating economics.

Five records to study first

1. 2008 NVCA/Bancroft oral history — broadest career, institution, deal, and failure record; paraphrase only.
2. 2018 CHM oral history — clearest concise statement of the people/market screen and team evolution.
3. Apple prospectus — contemporaneous control that corrects the most repeated spoken deal story.
4. Mike Markkula oral history — participant countervoice for the Apple referral and Hank Smith attribution.
5. Jupiter donor profile — best compact source for late service/philanthropy self-conception, read with its promotional boundary.

Unresolved spoken record and retrieval agenda

1. Resolve the HTTP-403 HBS “Origin Stories” and “On the Job” routes and capture the 2:51 award-video body lawfully; record episode identities, speakers, runtimes, segments, transcripts, and media-specific rights before deciding whether they are distinct works.
2. Recover the original OneWire/Open Door video and reconcile its complete Apple account with the prospectus and Markkula testimony.
3. Resolve the IDEXX route safety rejection and locate a separate authorized film asset; only then transcribe it, separate Crisp speech from Shaw narration, and identify the recording date and rights.
4. Fingerprint the CHM exhibit clip to its parent interview and record exact clocks; count it only as a manifestation if duplicated.
5. Obtain lawful access to catalog-described HBS speeches, interview recordings, release forms, and corrections under Mss:784 1946-2008 C932; access does not itself grant quotation or reproduction permission.
6. Retrieve partnership and company records for New England Nuclear, Venrock formation, Apple, Intel, Europe, Advent, Thermo Electron, and IDEXX to test retrospective rationales and role claims.
7. Repeat exact-title, archive, event, and transcript searches when collections change. Six located route families are not proof that no other speech or interview exists.

Researcher inference · strong: the spoken record supports a stable late-life account of relationship-based sourcing, people-and-market selection, patient institutional capital, specialist teamwork, long governance, and service. It does not establish a complete deal denominator, personal economics, consistent execution, or Crisp-only causality.

Trace the introducer and separate access from selection

• Rule: Map every referral chain and the information or trust it contributed; judge access quality separately from underwriting quality and outcome.
• Evidence status: Researcher inference · moderate. Crisp repeatedly benefited from relationship paths, but no inspected source records this as his formal rule or measures predictive value.
• Provenance and origin: The earliest personal example is Crisp's 1959 unsolicited approach after reading about Rockefeller; the operating platform predates him. Retrospective witness · moderate for the approach and contemporaneous record · strong for the platform. TIME, 1959 · CHM, pp. 7–9
• Mechanism and reasoning: Trusted intermediaries can lower search cost, establish identity, reveal work history, and make scarce opportunities reachable. They can also create correlated judgment, prestige bias, conflicts, and false comfort. Name the incremental information and rerun the case without the relationship halo.
• Historical and vehicle context: In a small 1960s venture field, Rockefeller's name, family capital, staff, and syndication ties created access uncommon to a new investor. That was a platform asset, not solely Crisp's repeatable skill. Researcher inference · strong. Rockefeller platform evidence
• When to use: Use for founder referrals, insider networks, repeat entrepreneurs, co-investor introductions, proprietary-sourcing claims, and any decision where prestige affects pace. Do not use trust as a substitute for customer, technical, legal, or integrity evidence.
• How to apply it: (1) name every introducer; (2) record relationship duration and incentives; (3) state the non-public information contributed; (4) identify conflicts and missing independent channels; (5) write the underwriting case without names; (6) set a disconfirming reference/data threshold; (7) kill or slow the deal if access is the only evidence.
• Examples:
  • Crisp → Rockefeller: reading a public article and writing directly created career access, but the original letter and hiring reasons are absent. Retrospective witness · moderate. CHM, pp. 7–9
  • Markkula → younger Hank Smith → Venrock → Crisp: the chain separates Apple access, partnership ownership, initial board representation, and later Crisp governance. Documented behavior · strong. Markkula, pp. 25–27 · Apple prospectus, pp. 21–28
  • Shaw → Crisp/Venrock: the founder credits Crisp with access and mentorship, but sponsor, decision, terms, board work, and economics remain unknown. Retrospective witness · moderate. Shaw memorial
  • Boundary—Intel: Arthur Rock and Charles B. Smith are supported financing/board actors; proximity does not make Intel a Crisp-sourced deal. Contemporaneous record · strong. Intel 1968 financial statement, pp. 2–3 and 6
• Evidence: The Apple filing and Markkula testimony independently establish the strongest application; TIME, CHM, and Shaw supply other relationship families. The evidence supports the diagnostic, not a quantified sourcing edge. Sourcing analysis
• Limits, failure modes, and exception ledger: Relationships can exclude outsiders, recycle consensus, hide misconduct, and shift credit to the most famous participant. Europe shows institutional access did not eliminate integrity risk. The missing opportunity/pass ledger prevents comparing referred and non-referred outcomes. Europe lab
• Evolution and contradictions: Crisp's public memory increasingly compresses Apple's shared chain into a “gut feeling” story. The filing and Markkula record restore multiple actors and staging; the derivative OneWire body cannot establish an intuition rule. OneWire note
• Modern VC translation (as of 2026-08-20): Researcher inference · moderate; conditional hypothetical; current-condition premises are assumptions, not verified facts. The referral map transfers; closed Rockefeller-style scarcity does not. Applicable signals are unique verifiable information, trusted work, and aligned incentives. Likely misuse is equating a prestigious source with a good company. Record source advantage separately, require an independent channel, and run a name-blind memo; a current-company example would be hypothetical without new research.

Require both people evidence and a reachable large market

• Rule: Approve only when job-relevant evidence supports the team and dated evidence supports a large, reachable customer problem; neither charismatic people nor abstract market size compensates automatically for failure of the other gate.
• Evidence status: Investor-stated · strong for Crisp's 2018 preference; researcher inference · provisional for consistent application and efficacy.
• Provenance and origin: Crisp says people come first and immediately adds the need for a large market. The earliest mapped public articulation is the 2018 CHM interview, not a contemporaneous 1960s memo. CHM transcript, printed pp. 12–17
• Mechanism and reasoning: People determine learning, hiring, integrity, and adaptation; reachable-market evidence determines whether successful execution can create scale. Requiring both reduces charisma-only and TAM-only errors, but still leaves timing, product, financing, terms, and competition.
• Historical and vehicle context: Early technical companies had scarce management depth, uncertain markets, long development, and limited capital. A family-backed vehicle could wait longer, while privileged access could bias personal judgment. Researcher inference · moderate. Historical context
• When to use: Use at seed/early growth, leadership changes, follow-ons, and any high-uncertainty market. Do not use appearance, social similarity, confidence, or reputation as people evidence; do not use top-down TAM without customer reachability.
• How to apply it: (1) define founder jobs; (2) collect direct-work and disconfirming references; (3) test integrity through inconsistencies and bad-news behavior; (4) identify customer, budget, urgency, and distribution; (5) quantify reachable market; (6) set independent people/market kill criteria; (7) name next-check evidence.
• Examples:
  • Apple—researcher inference · provisional: Markkula, Jobs, Wozniak, product planning, and an emerging market made both gates relevant, but Venrock's dated evaluation is missing. Apple lab
  • New England Nuclear—researcher inference · provisional: a technical/health-care team and hospital/regulatory market required separate tests; the original memo is absent. NEN lab
  • Europe—retrospective witness · provisional: four reported losses and two bookkeeping allegations show that name/reputation and market narratives cannot replace verified integrity, reporting, and local controls. Retrospective witness · provisional. NVCA note
  • Advent—contemporaneous record · strong for outcome; application insufficient public record: bankruptcy demonstrates that a funded company can fail; original people/market work is unavailable, so the model cannot be retrofitted. court record
• Evidence: CHM authenticates the statement; the Apple prospectus, Markkula history, court record, and NVCA failure account provide independent outcomes and limits, not documented applications. TALKS framework
• Limits, failure modes, and exception ledger: The rule lacks operational thresholds, contemporaneous applications, a pass ledger, and matched outcomes. Great people can enter small or badly timed markets; large markets attract competition and weak teams. An analyst can redefine either gate after outcome.
• Evolution and contradictions: The language is crisp in 2018 but the 2008 history contains more institutional narrative than a recorded scorecard. No public evidence shows Advent, Europe, or E&S caused a changed screen. Researcher inference · strong. TALKS evolution
• Modern VC translation (as of 2026-08-20): Researcher inference · moderate; conditional hypothetical; current-condition premises are assumptions, not verified facts. The dual gate transfers. Faster software/AI iteration changes evidence cadence, not the need for integrity, learning, budgets, retention, and distribution. Applicable signals are direct-work references, honest updating, usage/retention, customer budget, and efficient reach. Likely misuse is charisma plus enormous slide-deck TAM. Set written thresholds before the partner meeting; any present-day example is a labeled hypothetical absent current research.

Match capital duration to company duration

• Rule: Finance only when the vehicle’s legal duration, reserves, stakeholder liquidity, and follow-on authority fit the company’s development path.
• Evidence status: Researcher inference · moderate for the duration-fit model. Crisp retrospectively states a patient-capital preference (investor-stated · moderate); milestone/stop gating is researcher inference · strong as an analyst control, not Crisp doctrine.
• Provenance and origin: The 1969 partnership shift is the earliest supported institutional event; Crisp's late histories conflict on exact assets and calls but describe a more durable pool. CHM, pp. 12–16 · TALKS conflicts
• Mechanism and reasoning: Duration fit can prevent forced exits and underfunding; reserves buy learning. Without milestones, patience can fund denial, crowd out alternatives, and conceal weak marks. The causal chain requires actual terms, reserves, decisions, and counterfactuals—not the label “evergreen.”
• Historical and vehicle context: Pre-1969 family subscribers chose deal by deal; the partnership pooled assets/capital; later Venrock funds and trusts may have different rules. The exact 1969 term, fees/carry, liquidity, and succession remain unavailable. Vehicle table
• When to use: Use for deep technology, health care, regulated products, hardware/manufacturing, long adoption, and follow-on/rescue decisions. Do not use “long term” to waive product, solvency, integrity, or opportunity-cost thresholds.
• How to apply it: (1) as a researcher control, map company milestones/downside duration; (2) map fund term, extensions, reserves, recycling, LP liquidity, and authority; (3) model base/downside follow-ons; (4) define ownership/dilution; (5) set kill/re-underwrite thresholds; (6) reserve only when next evidence can change the decision; (7) plan secondary, sale, distribution, or stop paths.
• Examples:
  • Venrock formation—documented behavior · moderate: contributed assets and calls plausibly reduced deal-by-deal discontinuity; exact incentive effects remain untested. HBS collection
  • Apple—documented behavior · strong; rule application insufficient public record: two 1978 purchases show separate capital decisions; no public milestone explains the second. Apple prospectus, pp. 21–28
  • New England Nuclear—researcher inference · provisional: a long scientific/regulatory path plausibly benefits from duration fit, but entry/follow-on records are absent. NEN lab
  • Advent—contemporaneous record · strong for outcome; application insufficient public record: Chapter 11 shows patient capital cannot abolish insolvency and rescue decisions need evidence; capital response is unknown. Advent lab
• Evidence: HBS and CHM establish the institutional story; Apple's filing and Advent's court record independently show staged capital and failure. They do not prove a Crisp milestone system or superior return. Philosophy vehicle analysis
• Limits, failure modes, and exception ledger: Missing partnership terms, reserves, calls/distributions, follow-on decisions, and matched fixed-life outcomes keep support moderate. Long duration can create soft budgets, stale marks, entrenchment, and key-person risk. Apple cannot validate all patience; Advent prevents that inference.
• Evolution and contradictions: Crisp consistently praised patient capital, but the public corpus records no specific liquidity doctrine or process change after failures. Later vehicles cannot infer 1969 rules. Researcher inference · strong.
• Modern VC translation (as of 2026-08-20): Researcher inference · moderate; conditional hypothetical; current-condition premises are assumptions, not verified facts. Duration fit remains crucial, while fixed-life funds, continuation vehicles, secondaries, and frequent mark cycles add options/conflicts. Signals include time-to-proof, reserve capacity, term/extensions, LP liquidity, and market dependence. Likely misuse is calling unlimited follow-ons “patient.” Approve company and vehicle milestones together and require a stop/secondary scenario; a current example would be hypothetical here.

Match specialist expertise to the case

• Rule: Assign a person with relevant technical, clinical, regulatory, or commercial expertise to challenge the case, while keeping final underwriting and attribution collective and explicit.
• Evidence status: Researcher inference · provisional for the specialist-assignment model and deal-level efficacy; retrospective witness · moderate only for the underlying staffed-apprenticeship and later-specialization record.
• Provenance and origin: Crisp's 1960s account names senior technical/governance colleagues before he held authority; later histories name specialist partners including Evnin and others. NVCA history, printed pp. 24–38 · Evnin, pp. 19–21 and 61–63
• Mechanism and reasoning: Specialists identify failure modes, ask higher-resolution questions, access expert networks, and monitor domain milestones. They can create authority bias and attribution confusion. The model works when experts expose assumptions rather than decide by credential.
• Historical and vehicle context: A liberal-arts generalist investing across aviation, semiconductors, nuclear medicine, biotechnology, and computing needed distributed expertise. Durable capital and a growing partnership could support it; staffing costs, authority, and allocations are unavailable. Researcher inference · moderate.
• When to use: Use in deep tech, health care, regulated markets, unfamiliar geographies, and any case where a generalist cannot test the central risk. Do not outsource customer truth, capital allocation, ethics, or the final decision.
• How to apply it: (1) list thesis-critical unknowns; (2) assign an accountable domain lead; (3) obtain an independent expert; (4) record assumptions/conflicts/confidence; (5) translate technical evidence into customer, regulatory, capital, and timing consequences; (6) preserve dissent; (7) attribute sourcing, diligence, vote, and board work separately.
• Examples:
  • New England Nuclear—researcher inference · provisional: technical/health-care diligence was central, while Waterman/Walker and staff roles remain incomplete. NEN lab
  • Intel—contemporaneous record · strong: Rock organized financing and Charles B. Smith held the supported Rockefeller-side board role; sector importance does not make Crisp the specialist. Intel 1968 financial statement, pp. 2–3 and 6
  • IDEXX—retrospective witness · moderate: Shaw supports access/mentorship, but sponsoring specialist and diligence are unknown. IDEXX note
  • Europe—retrospective witness · provisional: alleged bookkeeping problems show market expertise without local audit/legal/governance capability is insufficient. Europe lab
• Evidence: Crisp and Evnin are related participant sources but different perspectives; Intel's primary statement, Shaw, and Europe bound applications. The record supports organizational need more strongly than a repeatable Crisp assignment method. Team attribution
• Limits, failure modes, and exception ledger: Deal-level assignments, expert reports, partner votes, misses, and outcomes are missing. Experts can be overconfident, correlated, late, conflicted, or unable to translate science into markets. A specialist partner's good work is not Crisp personal skill.
• Evolution and contradictions: The organization reportedly moved from a small generalist staff toward sector specialization, but titles do not establish decision rights. Crisp acknowledges team growth while legacy summaries compress it into individual leadership. Researcher inference · strong.
• Modern VC translation (as of 2026-08-20): Researcher inference · moderate; conditional hypothetical; current-condition premises are assumptions, not verified facts. Specialist review transfers, while online expert access and denser sector funds reduce scarcity. Signals are a thesis hinging on facts the IC cannot explain. Likely misuse is credential worship. Require the specialist to state falsifiers and the generalist to translate them into market, capital, and governance terms; current examples are hypothetical absent sourced 2026 cases.

Specify the governance mechanism; never count the board title

• Rule: Before taking or crediting a board role, name the intervention—recruiting, financing, audit, succession, strategy, or monitoring—the authority/information required, outcome measure, and escalation condition.
• Evidence status: Long board service is documented behavior · strong in selected cases; the mechanism-first rule is researcher inference · moderate because company-level interventions are usually absent.
• Provenance and origin: Crisp describes early board support and New England Nuclear as his first board; filings document Apple and AMSC tenure. The rule arises from comparing titles with missing actions and adverse governance evidence. HBS biography · Apple 1994 proxy
• Mechanism and reasoning: A board can improve information flow, leadership, capital planning, controls, and accountability. A title without time, authority, data, independence, and action can be ceremonial or harmful. Causal credit requires a dated problem, intervention, alternative, and result.
• Historical and vehicle context: Long-duration capital made extended boards feasible; public-company roles added disclosure, audit, committee, fiduciary, and litigation exposure. Rights, compensation, conflicts, and fund/person allocations remain incomplete. Vehicle/board context
• When to use: Use before accepting a seat, in quarterly planning, financing stress, executive succession, audit/control problems, and value-add claims. Do not use tenure, attendance, or company appreciation as a proxy for contribution.
• How to apply it: (1) state the board's current job; (2) establish information/authority; (3) assign owner/deadline; (4) define intervention/alternatives; (5) record dissent/conflicts; (6) measure result; (7) escalate, recruit, finance, stop, or leave at thresholds; (8) attribute execution to operators.
• Examples:
  • Apple—documented behavior · strong for tenure; researcher inference · provisional for intervention: Crisp replaced Hank Smith in 1980 and served to 1996; criticism/disclosure adversity prevent a uniformly effective narrative. Apple prospectus, printed pp. 21–28 · Los Angeles Times, “A Question of Leadership”
  • New England Nuclear—retrospective witness · moderate: Crisp's role is retrospective and specific interventions are absent; the company sale cannot prove causality. NEN lab
  • AMSC—documented behavior · strong for board; contemporaneous record · strong for legal exposure: filings establish tenure; litigation/settlement establish exposure, not personal wrongdoing or return. AMSC 2011 10-K · Lenartz order
  • IDEXX—retrospective witness · moderate: Shaw supports mentorship/access, but no board mechanism or economics are reconstructed. Shaw memorial
• Evidence: Apple and AMSC filings are independent primary records; contemporary criticism, Crisp's history, and Shaw supply distinct perspectives. They establish tenure/counterevidence more strongly than positive intervention causality. Governance postmortems
• Limits, failure modes, and exception ledger: Missing minutes, committee records, management testimony, alternative actions, and outcome measures make value-add claims provisional. Failure modes include deference, stale information, groupthink, conflict, delayed succession, compliance lapses, overreach, and credit capture. Company success and investor return diverge.
• Evolution and contradictions: Crisp's late narrative celebrates long boards; the 1994–1996 Apple record and later AMSC case demand a conditional rule. No public evidence shows criticism changed his process. Researcher inference · strong.
• Modern VC translation (as of 2026-08-20): Researcher inference · moderate; conditional hypothetical; current-condition premises are assumptions, not verified facts. Mechanism-first governance transfers; faster data, founder control, remote boards, and larger portfolios can reduce attention/authority. Signals are named information, hiring, audit, capital, or succession gaps the board can affect. Likely misuse is marketing seat count. Use an intervention charter, quarterly evidence, and exit/escalation threshold; a current example here would be hypothetical.

Evidence gaps and candidate models

The inventory excludes attractive slogans and analyst controls that the historical record does not establish as Crisp models:

• “Gut feeling.” Only a derivative OneWire summary survives; original media, wording, context, and decision process are uncaptured. route note
• Stage capital against milestones — analyst control merged with the duration model, not Crisp doctrine. Apple has two purchases, but no source ties the second to a named milestone or general Crisp rule. Retrieve approval memos/partner records. Apple filing
• “Learn, earn, return.” A service/life maxim in an edited donor context, not a demonstrated investment rule. Jupiter note
• Failure/exception ledger, company-versus-investor-return separation, and eight-role attribution. Necessary analyst controls, not Crisp doctrine.
• Geographic diversification/local-partner rule. Europe supplies a failed experiment, not a stable pre-stated rule.
• Price discipline, ownership target, reserve formula, exit doctrine, and power-law construction. No public writing, transcript, memo, or ledger supplies a reusable rule or three grounded applications.
• Board tenure equals value. Tenure is an input; Apple and AMSC prevent treating it as an outcome or model.
• Apple success / Intel investment. Outcomes and associations are not rules; Intel is not a documented Crisp deal.

Model-specific retrieval routes attempted are recorded in sources, writings, talks, and investments. The decisive missing bodies are HBS Mss:784 1946-2008 C932 writings, company/partner memos and votes, partnership/cash-flow records, board minutes, failure files, original OneWire video, and uncaptured HBS/IDEXX media. Until those records yield repeatable rules and applications, exclusion is stronger than padding.

What the evidence supports

The defensible favorable case is narrower than a conventional “great investor” biography. From roughly 1960 to 1997, Crisp plausibly helped orchestrate a durable Rockefeller-derived venture institution: relationship access fed opportunities into a staffed platform, long-duration capital reduced some fundraising pressure, specialists divided work, and board service created opportunities to help. Researcher inference · moderate. This is a falsifiable mechanism, not evidence of superior personal selection, a Crisp-only track record, or audited alpha. Profile thesis · vehicle audit

Apple is the strongest visible economic candidate only at the vehicle level. The prospectus records January and September 1978 Venrock purchases totaling $499,998 and a 3,801,822-share, 7.6% pre-IPO position. Markkula identifies the younger Hank Smith as the referral contact; the filing shows Smith preceded Crisp as the Venrock board nominee and Crisp succeeded him in October 1980. Documented behavior · strong. No inspected record supplies realized Venrock cash flows, a Crisp personal stake, or his incremental contribution. Apple prospectus, printed pp. 21–28 · Markkula oral history, printed pp. 25–27

Intel supports institutional lineage, not Crisp deal credit. The October 1968 financing predates Venrock; the statement gives $2.5 million of aggregate debentures but no Rockefeller allocation. Arthur Rock organized the financing, and Charles B. Smith is the supported Rockefeller-side board actor. Contemporaneous record · strong for the financing; insufficient public record for a Crisp source, check, lead, or board role. Intel 1968 financial statement, pp. 2–3 and 6 · Crisp CHM oral history, printed pp. 18–20

The strongest supported operating rule is the people-plus-reachable-market screen. Relationship sourcing, duration fit, specialist assignment, and mechanism-first governance are researcher reconstructions whose application remains incomplete. Investor-stated · strong for the screen; researcher inference · moderate for the conceptual mechanisms and researcher inference · provisional for most deal-level applications. CHM oral history, printed pp. 12–17 · five-model guide

What could falsify the thesis

The favorable thesis predicts that unseen pre-outcome files will repeatedly show Crisp sourcing or sponsoring opportunities, applying management/integrity and market tests, assigning relevant specialists, reserving or following on for duration reasons, and causing identifiable recruiting, financing, audit, succession, strategy, or monitoring interventions. It predicts better matched outcomes after controlling for Rockefeller access, vehicle duration, partner, sector, vintage, stage, and syndicate. Researcher inference · moderate.

It would fail or weaken if memoranda and votes assign celebrated work to other partners; the people/market screen appears only in late winner narratives; ex-Apple cash flows underperform matched cases; boards show ceremonial or delayed intervention; vehicle terms were not meaningfully patient; founders, co-investors, specialists, or platform access explain outcomes without incremental Crisp contribution; or failures produced no learning. Retrieval ledger

The strongest skeptical explanation presently fits at least as well: Crisp was an effective steward inside an unusually advantaged Rockefeller platform, while access, team members, founders, co-investors, and one conspicuous Apple outlier explain most visible value. The missing opportunity denominator and cash-flow ledger prevent choosing among institutional skill, personal selection, and outlier luck. Researcher inference · strong. Profile audit · case against greatness

Attribution and denominator audit

The final inventory is a candidate ledger, not a portfolio: eighteen named company/relationship labels, five named passes, and five unnamed European slots whose overlap is unresolved. Apple alone is sufficiently reconstructed at a bounded entry/board-sequence level; four named cases are partial; two shared-deal candidates come from Franklin Pitcher Johnson; eleven are board/relationship-only or funding-unverified. Researcher inference · strong. A funded coverage fraction is not computable because issuers, follow-ons, spinouts, ordinary outcomes, rejects, vehicles, and cash flows are incomplete. Mechanical reconciliation · Venrock disclosure

Crisp personally is not the Rockefeller family office, RBI/RF&A, Venrock Associates, later funds, trusts, Rockefeller Financial Services, or a board biography. Sourcing, sponsorship, diligence, approval, negotiation, board work, follow-on, exit, and economics are separate roles; unknowns remain unknown. Eight-role grid

The failure and anti-portfolio record prevents winner-only synthesis. Advent entered Chapter 11 in 1981; Crisp retrospectively reported four losses in a five-company European experiment and characterized Evans & Sutherland as disappointing; Apple and AMSC add adverse governance evidence without findings of personal wrongdoing. Xerox/Haloid, Tandem, Genentech, Amgen, and Compaq form an incomplete pass ledger. Contemporaneous record · strong for Advent and legal/filing facts; retrospective witness · provisional for Europe/E&S; retrospective witness · moderate for named pass accounts. Postmortems · pass ledger

Transfer limits for modern VCs

The five models transfer as questions, not proof of historical alpha: trace the introducer, test people and reachable market, match capital and company duration, assign specialist expertise, and specify the governance mechanism. Model inventory Their 2026-08-20 translations are conditional analyst assumptions or hypotheticals because this run did not independently establish current claims about AI cadence, secondaries, online networks, sector-fund density, remote boards, or founder control. Researcher inference · provisional.

The largest misuse is to translate Rockefeller privilege into generic “network skill,” long-lived family capital into a fixed-life fund rule, or board tenure into value creation. A modern analyst should record referral source, security/ownership, reserve/liquidity constraints, specialist assignment, decision rights, and specific governance acts before claiming transferability. Researcher inference · strong. Modern matrix

Unresolved evidence

The decisive legitimate retrievals remain the HBS Peter O. Crisp papers, call number Mss:784 1946-2008 C932; a lawful copy of Crisp's Done Deals chapter at printed pp. 107–112; vehicle agreements and cash-flow schedules; deal memoranda/votes/board minutes; and company records. Archive custody is not authorship, body access, copyright, quotation, or reproduction permission. HBS finding aid · written-corpus accounting

The direct-voice inventory is ten mapped rows collapsing to six route families and two full independent transcripts. The 2008 NVCA/Bancroft body is paraphrase-only absent written NVCA permission. HBS podcast bodies returned HTTP 403; the CHM exhibit exposed no inspected parent fingerprint; the IDEXX film route yielded no separate lawful media asset; and the original OneWire body remains unavailable. Page/brochure, memorial, and derivative text were processed; uncaptured wording was excluded. Researcher inference · strong. TALKS reconciliation · HBS route · CHM route · IDEXX route

Central-claim citation audit

Ordinary-claim citation audit

The sample was fixed across every core document before the completion-state change.

Independent deal and team cross-check

Twenty-point acceptance evidence

All twenty conditions pass after correction. This acceptance applies to the bounded public record; it does not convert missing archives, cash flows, or person-level economics into evidence.

Every - [x] row was processed to the access boundary shown and reconciled into the package; the marker does not imply that an inaccessible body was read or that a source independently corroborates its own claim.

Direct voice, interviews, and public appearances

• ★★★ | Peter O. Crisp: Venture Capital Greats oral history | https://digicoll.lib.berkeley.edu/record/103633/files/vcg-crisp.pdf | interviewed 2008-10-21; published 2009 | full 78-page NVCA/Bancroft transcript; reliability A for custody and attributed speech, B for retrospective accuracy | Richest first-person body on life, Rockefeller staffing, Venrock, deals, misses, governance, and philosophy. Front matter permits research use but bars quotation for publication without written NVCA permission: paraphrase only.
• ★ | CHM preservation route for the 2008 NVCA oral history | https://archive.computerhistory.org/resources/access/text/2019/03/102740500-05-01-acc.pdf | preserved 2019; interview 2008 | duplicate manifestation; current route returned 404; reliability A for catalog identity | Do not count independently from the Berkeley/NVCA transcript; retain as a dead-link/manifestation control.
• ★★★ | Oral History of Peter Crisp | https://archive.computerhistory.org/resources/access/text/2019/04/102717367-05-01-acc.pdf | recorded 2018-08-30; published 2019 | full CHM 27-page transcript, ref. X8765.2019; reliability A for custody and speech, B for memory | Distinct later interview; printed pp. 8–9 cover career start/New England Nuclear, pp. 12–16 Venrock and criteria, pp. 15–21 Apple/Intel, pp. 23–24 misses and market change.
• ★★★ | HBS 2024 Alumni Achievement Awards — Peter O. Crisp | https://www.alumni.hbs.edu/awards/Pages/default.aspx?year=2024 | 2024-05-23 | official HBS profile with linked video/podcasts; reliability A for award/career metadata, B for edited framing | Current institutional chronology, board claims, recognition, and direct-media routes; award page, brochure, video, and podcasts form one editorial family.
• ★★ | HBS 2024 award recipient brochure | https://www.alumni.hbs.edu/Documents/Awards/AAA24_Brochure.pdf | 2024 | official HBS PDF; access full; reliability B | Edited Crisp profile and selected direct remarks; process separately only where its written body differs from the award page.
• ★★ | Jupiter Medical Center Foundation donor profile | https://www.jmcfoundation.org/donor-stories/peter-crisp | fall 2018 | edited donor interview/profile; access full; reliability B | Direct remarks on “learn, earn, return,” Rockefeller contact, career, and health-care philanthropy; promotional setting requires corroboration.
• ★★ | OneWire/Open Door Apple interview — surviving summary | https://www.wallstreetoasis.com/forum/off-topic/early-apple-investor-why-my-team-went-with-our-gut-feeling-to-give-steve-jobs | circa 2013 | derivative summary/embedded-video route; original video provenance incomplete; reliability C for summary, A/B if original recovered | Routes Crisp's Apple story and remembered $300,000/10%/1979 shorthand; the 1980 prospectus controls chronology and economics.
• ★★ | Computer History Museum — The Next New Thing | https://computerhistory.org/stories/the-next-new-thing/ | current exhibit, accessed 2026-08-20 | official CHM exhibit with embedded Crisp oral-history video; reliability A for custody, B for framing | Short direct-video route and historical context; do not count excerpts as independent from the source oral history.
• ★★ | HBS Skydeck — 2024 award recipient podcast routes | https://www.alumni.hbs.edu/awards/Pages/default.aspx?year=2024 | 2024 | official HBS page linking Origin Stories and On the Job; partial route, audio/transcript not captured | The two linked story routes returned HTTP 403 during the 2026-08-20 recheck. Treat the award page, video, and podcasts as one program family until bodies, clocks, and separate media rights are verified; the NVCA transcript restriction does not govern this HBS family.
• ★★ | IDEXX founder memorial and film route | https://www.blackpointgroup.com/entrepreneurship/remembering-peter-o-crisp/ | 2026-08-08 | founder memorial with embedded/linked film; reliability B for witness memory | The exact route was rejected by the browser safety layer during the 2026-08-20 recheck, and a bounded exact-domain search exposed no separate film or transcript asset. Retain the earlier captured memorial account as retrospective witness evidence; do not represent the film body as inspected.

Writings, books, and archival collections

• ★★★ | Peter O. Crisp papers, 1946–2008 | https://hollisarchives.lib.harvard.edu/catalog/bak00213 | collection Mss:784 1946-2008 C932 | HBS Baker Library finding aid, 1.5 linear ft., 3 boxes/6 folders and 74 components; catalog full, bodies mostly on-site/HarvardKey | Highest-value route to investment performance/partner analyses, Crisp notes and speeches, Rockefeller/Venrock records, and a defensible portfolio denominator; do not imply unseen bodies were read.
• ★★★ | Peter O. Crisp papers — Venrock Associates series | https://hollisarchives.lib.harvard.edu/catalog/bak00213_bak00213c00001 | records circa 1946–2008 | HBS component-level finding aid; metadata access, bodies restricted/on-site | Routes original company, portfolio, performance, and partnership files; later phases must name the exact component and access boundary.
• ★★★ | Done Deals: Peter Crisp/Venrock chapter | https://books.google.com/books/about/Done_Deals.html?id=ZdG3wAEACAAJ | 2000; Crisp chapter at printed pp. 107–112 | catalog metadata only; Udayan Gupta is editor; licensed chapter body required | Confirms editor, title, contributor, and printed-page span only. It supports no chapter-body claim about philosophy, deals, vehicle design, or performance until a lawful copy is inspected.
• ★★ | Done Deals publisher/catalog route | https://www.biggerbooks.com/done-deals-gupta-udayan/bk/9780875849386 | 2000 | licensed-book metadata/contents; partial access | Confirms Crisp's inclusion and lawful retrieval path; same underlying work as the Google Books record, not independent evidence.
• ★★ | VC: An American History | https://books.google.com/books/about/VC.html?id=uSmWDwAAQBAJ | 2019; relevant discussion pp. 167–172 | scholarly secondary based partly on HBS records; partial preview; reliability B | Best analytical route to Venrock's early portfolio, Hank Smith's Apple role, and reported PME excluding Apple; retrieve tables, footnotes, and methodology before using economics.
• ★ | HBS Crisp papers PDF/finding-aid download route | https://hollisarchives.lib.harvard.edu/catalog/bak00213 | current | archive metadata/reading-room route; body access partial | Later phases should request lawful reading-room or digitization access only with separate authorization; no outreach was made in this run.

Company filings and deal records

• ★★★ | Apple Computer 1980 prospectus | https://www.sec.gov/files/18-02062-FOIA.pdf | 1980-12 | SEC-hosted primary prospectus; full | Controls Venrock's January/September 1978 purchases, $499,998 basis, 3,801,822 shares/7.6% pre-IPO, Henry S. Smith's prior board role, and Crisp's October 1980 succession.
• ★★★ | Apple Computer 1980 prospectus — stable historical scan | https://deramp.com/swtpc.com/Apple/Apple_IPO.pdf | 1980-12 | full historical scan; reliability A for reproduced filing | Printed pp. 21–28 are a practical locator mirror of the SEC-hosted filing; one underlying work, not independent evidence.
• ★★★ | Apple 1994 definitive proxy | https://www.sec.gov/Archives/edgar/data/320193/0000891618-94-000258.txt | 1994-12-12 | SEC filing; full | Confirms Crisp as director since 1980 and records the one-month-late Section 16 report involving trust sales and disclaimed beneficial interest.
• ★★★ | Apple 1995 definitive proxy | https://www.sec.gov/Archives/edgar/data/320193/0000891618-95-000750.txt | 1995-12-19 | SEC filing; full | Confirms Crisp remained a director and supplies board/committee context near the end of his tenure.
• ★★ | Apple 1996 definitive proxy | https://www.sec.gov/Archives/edgar/data/320193/000091205796030278/0000912057-96-030278.txt | 1996-12-27 | SEC filing; full | Crisp's omission helps bound the board endpoint; use with contemporaneous departure reporting rather than inferring the exact date from absence alone.
• ★★★ | Apple 1998 Form 10-K405 | https://www.sec.gov/Archives/edgar/data/320193/000104746998044981/0001047469-98-044981-index.htm | 1998-12-23 | SEC filing; full index/document route | Primary litigation-status control for shareholder allegations connected to prior board conduct; allegations are not findings.
• ★★★ | Intel 1968 convertible-note memorandum | https://law.stanford.edu/wp-content/uploads/2023/01/Intel-Convertible-Note-220920.pdf | 1968 | archival primary transaction document; full | Controls financing structure and participants; Intel financing predates Venrock, and no inspected record establishes a Crisp personal check or Intel board role.
• ★★★ | Intel 1968 financial statement | https://www.intel.com/content/dam/www/central-libraries/us/en/documents/2025-05/history-1968-financial-statement.pdf | 1968; official historical release | Intel-hosted primary financial statement; full | Records aggregate $2.5 million convertible debentures; does not allocate Rockefeller/Crisp economics.
• ★★★ | American Superconductor 2011 Form 10-K | https://www.sec.gov/Archives/edgar/data/880807/000095012311086249/b85132be10vk.htm | 2011 | SEC filing; full; director section lines 4415–4422 | Controls Crisp's board tenure, later Rockefeller role, and the company's claim that he served on 43 public/private boards; board count is not an investment denominator.
• ★★ | American Superconductor 1998 proxy | https://ir.amsc.com/static-files/077d345e-a885-4820-ba8b-d687269e886c | 1998 | company-filed Schedule 14A; full | Contemporary biography and board-role cross-check after Crisp's Venrock retirement.
• ★★ | Lenartz v. American Superconductor order | https://cases.justia.com/federal/district-courts/massachusetts/madce/1%3A2011cv10582/135654/92/0.pdf | 2012 | federal-court order; full | Controls the claims and procedural posture naming directors including Crisp; not a finding of Crisp wrongdoing.
• ★★ | American Superconductor settlement notice | https://veritaglobal.net/Documents/ALZ0001/ALZ_NOT-POC2.pdf | 2013 | court-approved settlement notice; full | Records the $10 million settlement and terms; must preserve non-adjudication and insurance/payment boundaries.
• ★★ | In re Advent Corp. | https://www.casemine.com/judgement/us/59149090add7b04934578e65 | 1981 | bankruptcy decision reproduction; full/partial locator | Confirms Advent's March 17, 1981 Chapter 11 filing and challenges Crisp's later categorical no-bankruptcy recollection.

Participant, founder, partner, and team controls

• ★★★ | Mike Markkula oral history | https://archive.computerhistory.org/resources/access/text/2012/08/102746385-05-01-acc.pdf | recorded 2009; published 2012 | CHM participant transcript; full; reliability A for custody, B for memory | Printed pp. 25–27 distinguish the two Henry/Hank Smiths, identify the younger Smith as Apple's Venrock contact, and constrain Crisp-only sourcing credit.
• ★★★ | Anthony B. Evnin oral history | https://digicoll.lib.berkeley.edu/record/103633/files/evnin_anthony_donated.pdf | interviewed 2009 | full Bancroft/NVCA transcript; reliability A for custody, B for memory | Independent partner evidence on hiring, mentoring, people judgment, biotechnology specialization, IDEXX, and team/vehicle structure.
• ★★ | Franklin Pitcher Johnson oral history | https://digicoll.lib.berkeley.edu/record/103604/files/johnson_franklin.pdf | interviewed 2008; published 2009 | full Berkeley participant transcript; reliability A for custody, B for retrospective accuracy; quotation restricted | Printed pp. 31–32 support an introduction to McCourtney, Crisp, Smith, and the Rockefeller office followed by shared Coherent Radiation and BioSurface Technologies relationships. They do not allocate sourcing, approval, board work, vehicle, terms, or returns to Crisp.
• ★★ | C. Richard Kramlich oral history | https://archive.computerhistory.org/resources/access/text/2016/03/102740064-05-01-acc.pdf | recorded earlier; preserved 2016 | CHM participant transcript; full | Cross-checks Apple referral/financing and identifies Charles Smith as a key Rockefeller-side Intel-era actor; retrospective and sometimes imprecise.
• ★★ | Michael C. Brooks oral history | https://archive.computerhistory.org/resources/access/text/2019/03/102740498-05-01-acc.pdf | recorded earlier; preserved 2019 | CHM/NVCA transcript; full | Independent Apple financing/intermediary evidence, including Morgan Stanley and Venrock contact paths.
• ★★ | Robert Higgins HBS Entrepreneurs oral history | https://www.library.hbs.edu/content/download/60446/file/Higgins_Robert.pdf | 2010-era interview | official HBS transcript; full | Witness evidence of Crisp's mentoring and advice to a prospective venture entrant; not deal-performance proof.
• ★★ | T. Bondurant French oral history | https://archive.computerhistory.org/resources/access/text/2021/09/102792280-05-01-acc.pdf | preserved 2021 | CHM/NVCA transcript; full | Controls later Venrock outside-capital evolution and cautions against projecting current fund structure backward.
• ★★ | David Shaw memorial of Peter Crisp | https://www.blackpointgroup.com/entrepreneurship/remembering-peter-o-crisp/ | 2026-08-08 | founder/portfolio-company witness; full | IDEXX access, mentoring, Apple board claim, and recent death confirmation; laudatory retrospective with attribution limits.

Contemporary press, criticism, memorials, and context

• ★★★ | TIME — Space-Age Risk Capitalist | https://time.com/archive/6802473/business-space-age-risk-capitalist/ | 1959 | contemporary magazine profile of Laurance Rockefeller; full/archival | The article Crisp says prompted his letter; controls the public ideas available to him in 1959 and Rockefeller's pre-Crisp program.
• ★★★ | TIME — Boom Time in Venture Capital | https://time.com/archive/6700583/boom-time-in-venture-capital/ | 1981-08-10 | contemporary magazine report; full | Reports Advent's bankruptcy while quoting Crisp's no-major-blooper claim; also supplies contemporary capital-market and regulatory context.
• ★★ | Washington Post — Du Pont Gives Harvard $6 Million | https://www.washingtonpost.com/archive/business/1981/06/30/du-pont-gives-harvard-6-million/c94ef7d7-fab6-4de0-a400-a765bc349cbd/ | 1981-06-30 | contemporary press; access partial/full by route; reliability B | Dates and sizes the New England Nuclear acquisition at about $430 million in stock, correcting Crisp's later memory without implying Venrock proceeds.
• ★★★ | Los Angeles Times — A Question of Leadership | https://www.latimes.com/archives/la-xpm-1996-01-24-fi-28113-story.html | 1996-01-24 | contemporary reported criticism; full | Strong adverse source on Apple's board, including the claim that Crisp and other directors deferred to Markkula; allegation/witness reporting, not adjudication.
• ★★ | San Francisco Chronicle — Apple Loses Yet Another Top Official | https://www.sfgate.com/business/article/Apple-Loses-Yet-Another-Top-Official-Longtime-2979301.php | 1996 | contemporary press; full | Bounds Crisp's Apple departure and board crisis context.
• ★★ | Peter O. Crisp family death notice | https://www.legacy.com/us/obituaries/nytimes/name/peter-crisp-obituary?id=62200231 | published 2026-08-16; death 2026-08-04 | family notice carried by NYT/Legacy; full; reliability A for family-supplied dates, B for career claims | Current identity/death control and late-life chronology; promotional aggregate achievements require independent support.
• ★★ | Axios Pro Rata — Peter Crisp death and Venrock statement | https://www.axios.com/newsletters/axios-pro-rata-67141a7b-cecf-4f59-a3e9-70d7283a1bf8 | 2026-08-06 | current newsletter; reliability B | Independent current reporting of death and a quoted Venrock memorial; board-tenure shorthand remains secondary.
• ★★ | Venrock — current portfolio disclaimer | https://www.venrock.com/contact | current, accessed 2026-08-20 | official firm disclosure; full | States displayed investments are incomplete/selected in part for positive performance, so the current site cannot supply a historical denominator.
• ★ | NVCA Lifetime Achievement award reference | https://nvca.org/press_releases/dixon-doll-presented-with-lifetime-achievement-in-venture-capital-award/ | current archive | official association award list; full | Corroborates Crisp's 2004 award; recognition is not track-record evidence.

Historical context and completed-peer controls

• ★★★ | HBS — Peter O. Crisp papers biographical/historical note | https://hollisarchives.lib.harvard.edu/catalog/bak00213 | current finding aid | official archive context | Defines the Rockefeller Brothers/RBI-to-Venrock institutional chronology and cofounders; same collection family as the archival rows above.
• ★★ | CHM — The Next New Thing venture timeline | https://computerhistory.org/stories/the-next-new-thing/ | current exhibit | official museum synthesis with primary clips; reliability B for historical framing | Routes postwar VC, ARD, Rockefeller, Rock, and contemporaries; verify claims against underlying records.
• ★★ | Laurance Rockefeller completed canon package | ../003-laurance-rockefeller/_profile.md | repository peer, reviewed/complete | local synthesis with underlying citations | Primary comparator for sponsor, family capital, RBI/Venrock formation, philanthropy, and attribution boundaries.
• ★★ | Arthur Rock completed canon package | ../006-arthur-rock/_profile.md | repository peer, reviewed/complete | local synthesis with underlying citations | Comparator and transaction control for Intel/Apple syndication, boards, selection, and personal-partnership structure.
• ★★ | Reid Dennis completed canon package | ../004-reid-dennis/_profile.md | repository peer, reviewed/complete | local synthesis with underlying citations | Same-era comparator for syndication, long governance, sourcing, and vehicle evolution; confirm live completion before SYNTH.
• ★ | Small Business Investment Act historical record | https://www.govinfo.gov/content/pkg/STATUTE-72/pdf/STATUTE-72-Pg689.pdf | 1958 | official statute; full | Controls the SBIC policy backdrop; Crisp's family capital did not make Venrock an SBIC by implication.
• ★ | ERISA prudent-man rule amendment history | https://www.govinfo.gov/content/pkg/FR-1979-06-26/pdf/FR-1979-06-26.pdf | 1979-06-26 | Federal Register; full | Context for the institutional-capital expansion Crisp later described; do not assign causation without further evidence.

Coverage assessment

Inventory and access accounting

• Inventory: 53 rows across direct voice/appearances (10), writings/archives (6), filings/deal records (13), participant/team controls (8), press/adverse/context (9), and historical/peer controls (7). Mirrors and manifestations are retained only when labeled as one source family.
• Priority: 20 ★★★ must-process, 28 ★★ should-process, and 5 ★ retrieval/control rows. Recount mechanically before later phase closeout if rows change.
• Access as of 2026-08-20: two full, distinct Crisp oral-history bodies are public; the 2008 body is paraphrase-only absent NVCA permission. Most filings and court/press controls are public. Done Deals requires lawful licensed access. The HBS Crisp papers are cataloged but much of the body requires HarvardKey, digitization, or reading-room access; no outreach or archive visit was attempted or authorized.

Search scope, variants, and identity controls

Searches covered Peter O. Crisp, Peter Ottley Crisp, Peter Crisp with Venrock, Rockefeller, Apple, Intel, Thermo Electron, American Superconductor, IDEXX, oral history, interview, speech, paper, writing, lawsuit, SEC, criticism, failure, bankruptcy, and obituary. Laurance Rockefeller was searched with the correct spelling and the common Laurence error. Results for the Australian politician/councillor, metaphor scholar, UK legal educator, plant scientist, author, and unrelated Australian entities were excluded.

Direct voice and archive routes

The direct-voice denominator currently contains two independent long oral histories, one donor interview, the HBS award media family, the OneWire/Open Door route, CHM exhibit clips, and an IDEXX film lead. The 2008 Berkeley and dead CHM preservation URLs are one work. The HBS papers—call number Mss:784 1946-2008 C932—remain the decisive route to Crisp's unpublished notes, speeches, partner analyses, company files, and reported performance; metadata is not content analysis.

Candidate portfolio denominator and attribution boundaries

The scoped public candidate universe contains 18 named company or relationship labels: Apple, Intel/predecessor capital, New England Nuclear, Advent, IDEXX, Evans & Sutherland, Thermo Electron, Thermedics, ThermoTrex, Thermo Power, American Superconductor, Itek, Galileo Electro-Optics, Echelon, Acadia Risk Management, U.S. Trust, Coherent Radiation, and BioSurface Technologies. It also contains five named passes—Xerox/Haloid, Tandem, Genentech, Amgen, and Compaq—and a separately reported five-slot European cohort whose names and overlap are unresolved. The labels are positively selected and mix Crisp-sponsored deals, partner or syndicate relationships, predecessor-family capital, board-only associations, and firm-wide outcomes; the passes are opportunity controls, not funded portfolio companies. The current firm site explicitly disclaims completeness. A coverage fraction is therefore not computable until the HBS schedules and vehicle/company records yield a deduplicated opportunity and cash-flow ledger. Keep personal, Rockefeller-family, RBI/RF&A, 1969 Venrock, later funds, trusts, and board-service evidence separate.

Conflicts, adverse evidence, and unresolved controls

Later phases must preserve rather than average conflicts over Crisp's 1960/1968 start-year slip; five versus seven contributed holdings; $1.5 million versus $2.5 million capital call; Apple 1978 primary dates versus remembered 1979; New England Nuclear timing/value; and the no-bankruptcy recollection versus Advent. Apple board criticism, Section 16 lateness, Apple shareholder allegations/settlement, and Lenartz/AMSC settlement are bounded adverse evidence, not findings of personal wrongdoing. No bounded search surfaced a Crisp-specific criminal or regulatory sanction; absence is not proof.

Historical context and peer routes

Context routes cover the 1958 SBIC statute, 1979 prudent-man change, postwar technology/defense environment, scarce early venture supply, family-office syndication, and later institutional-capital expansion. The closest currently completed comparison routes are Laurance Rockefeller for sponsor/vehicle/philanthropy, Arthur Rock for Intel/Apple syndication and boards, and Reid Dennis for same-era sourcing/governance/vehicle evolution. Bill Draper remains active and is not eligible as a completed peer.

Highest-value retrievals

1. Inspect the HBS Crisp collection component bodies and reconstruct the 1969 partnership asset/capital mechanics, complete company denominator, and cash-flow/performance schedules.
2. Obtain a licensed Done Deals chapter and create a paraphrase-only source note with printed-page locators and editor/authorship boundaries.
3. Acquire exact HBS podcast/video clocks, the original OneWire video, and the IDEXX film; distinguish replays and summaries from originals.
4. Retrieve Apple board minutes/Kostick settlement materials, original Venrock approval memoranda, and company filings for every claimed Crisp board/deal.
5. Reproduce any Nicholas PME claim from its table, footnotes, cash flows, benchmark, dates, gross/net basis, and Apple-exclusion method before using it.

Source notes